Platinum Investment Management LTD Albireo Pharma, Inc. Transaction History

Platinum Investment Management LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$18.01 - $23.78 $718,905 - $949,226	39,917 Added 14.95%	306,834 $6.63 Million
Q3 2022 Nov 14, 2022	BUY	$16.32 - $26.37 $621,726 - $1 Million	38,096 Added 16.65%	266,917 $5.17 Million
Q2 2022 Aug 11, 2022	SELL	$18.54 - $37.29 $703,092 - $1.41 Million	-37,923 Reduced 14.22%	228,821 $4.54 Million
Q1 2022 May 13, 2022	SELL	$23.94 - $33.74 $1.17 Million - $1.65 Million	-48,918 Reduced 15.5%	266,744 $7.96 Million
Q4 2021 Feb 11, 2022	BUY	$21.19 - $31.29 $1.49 Million - $2.2 Million	70,281 Added 28.64%	315,662 $7.35 Million
Q3 2021 Nov 09, 2021	BUY	$27.36 - $35.98 $1.08 Million - $1.42 Million	39,489 Added 19.18%	245,381 $7.66 Million
Q2 2021 Aug 11, 2021	BUY	$28.9 - $36.87 $4.13 Million - $5.26 Million	142,771 Added 226.19%	205,892 $7.24 Million
Q1 2021 May 13, 2021	BUY	$32.03 - $42.85 $2.02 Million - $2.7 Million	63,121 New	63,121 $2.23 Million

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.